Trump Launches ‘TrumpRx’ Program to Slash Drug Prices Nationwide

The initiative marks one of the most ambitious efforts yet to tackle high out-of-pocket drug costs in the United States and is being hailed by administration officials as a historic victory for patients who have long paid more than those in other developed nations.

The program is built around a network of “Most-Favored-Nation” pricing agreements between the U.S. government and participating pharmaceutical companies. Under the deals, drugmakers agree to offer Americans the same or lower prices than those charged to patients abroad — a significant shift after decades of higher domestic pricing.

“Last night, President Trump delivered on a core promise to the American people — ending the era where Americans pay far more for the same drugs than patients overseas,” the White House said in a statement. “TrumpRx means lower prices at the pharmacy counter, starting now.”